WO2026092511 - ANTI-ITGB6 ANTIBODIES AND USES THEREOF

National phase entry is expected:
Publication Number WO/2026/092511
Publication Date 07.05.2026
International Application No. PCT/CN2025/130880
International Filing Date 29.10.2025
Title **
[English] ANTI-ITGB6 ANTIBODIES AND USES THEREOF
[French] ANTICORPS ANTI-ITGB6 ET LEURS UTILISATIONS
Applicants **
BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.
Inventors
SHANG, Chengzhang
ZHANG, Na
LI, Mengran
YANG, Yi
SHEN, Yuelei
Priority Data
PCT/CN2024/127943   29.10.2024   CN
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
译文

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2967
EPO Filing, Examination, Granting28779
Japan Filing, Examination, Granting3108
South Korea Filing, Examination, Granting4196
USA Filing, Examination, Granting16540
MasterCard Visa
Total: 55,590
Contact Us
Abstract[English] Provided are anti-ITGB6 antibodies, antigen-binding fragments, and the uses thereof.[French] L'invention concerne des anticorps anti-ITGB6, des fragments de liaison à l'antigène et leurs utilisations.